Sign inJoin waitlistJoin the waitlist

Ming Yin

Physician · MUSC Health

Credentials: · · · · ·

History

MUSC Health
2026–Present

Hematology and Medical Oncology
Penn State Milton S Hershey Medical Center
2014–2017
Internal Medicine
Geisinger Medical Center
2011–2014
Medical School of Nanjing
1997–2001

Research

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
The Lancet Oncology · 2014 · 788 citations
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis
Systematic review or meta-analysis · The Oncologist · 2016 · First of 10 authors · 391 citations
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study
The Lancet Oncology · 2014 · 209 citations

Monika Joshi
9 papers
YY
Yuanquan Yang
9 papers
Edmund Folefac
8 papers
Joseph Drabick
8 papers
Steven Clinton
8 papers
Zhongxing Liao
8 papers
Claire Verschraegen
7 papers
PM
Paul Monk
7 papers
AM
Amir Mortazavi
6 papers
AP
Anish Parikh
6 papers
Sheldon Holder
6 papers
Daniel Gomez
5 papers